CHAI
LIVE

Serial Number

87814862

Owner

CHAI INC.

Attorney

CHAI INC.

First Use Date

Mar 30, 2017

Filing Date

Feb 28, 2018

Add to watchlist:

No watchlists yet
View on USPTO

CHAI Trademark

Serial Number: 87814862 • Registration: 5962171

CHAI is a trademark filed by CHAI INC. on February 28, 2018. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

CHAI INC. (2 trademarks)

990 RICHARD AVENUE, SUITE 110
SANTA CLARA, CA 95050

Entity Type: 03

Chai Biotechnologies Inc.

990 Richard Avenue, Suite 110
Santa Clara, CA 95050

Entity Type: 03

Trademark Details

Filing Date

February 28, 2018

Registration Date

January 14, 2020

First Use Anywhere

March 30, 2017

First Use in Commerce

March 30, 2017

Published for Opposition

March 19, 2019

Goods & Services

DNA amplification apparatus, namely, thermocyclers for scientific or medical research use; downloadable software for use with thermocyclers and DNA amplification devices for use in operating and controlling quantitative polymerase chain reaction (qPCR) thermocyclers, for use in conducting analysis of real-time polymerase chain reaction (PCR) and quantitative polymerase chain reaction (qPCR) data including amplification curve analysis, Cq calling, melt curve analysis, high resolution melt (HRM) quantification, and for use in test kit analysis for conducting presence and absence analysis, quantitative analysis, and analysis of control reactions; downloadable software for use in DNA and RNA analysis and sequencing, detection of genetic mutations, and detection of pathogens; downloadable software for gene analysis and sequencing, DNA and RNA analysis and sequencing, and identification of pathogens, allergens, bacteria, organisms, mold, plants, food, and biowarfare agents for use in medical diagnosis and treatment, scientific research and development, education, medical testing, veterinary diagnostics, food safety testing, water quality testing, beer quality testing, DNA tracing, food fraud prevention, and biosecurity

Reagents for use in gene analysis and sequencing as well as DNA and RNA analysis and sequencing, namely, polymerase chain reaction (PCR) master mixes, polymerase chain reaction (PCR) reagents and enzymes, polymerase chain reaction (PCR) test kits containing DNA primers and template control DNA for polymerase chain reaction (PCR), all for scientific and medical research use; Reagents for use in scientific apparatus for chemical or biological analysis; Reagents for in vitro use in biochemistry and cell culture reagents for scientific and research use; Reagents for scientific and research use used in the collection, storage and preparation of materials for gene analysis and sequencing as well as DNA and RNA analysis and sequencing, and in DNA extraction systems for crude lysates, DNA purification systems and cell filtration systems; Biochemical reagents used for non-medical purposes; Reagents for use in scientific apparatus for chemical or biological analysis; Reagents for in vitro use in biochemistry and microbiology; Cell culture reagents for scientific and research use; Reagents for scientific or research use used in detecting pathogens and genetic mutations, namely, test kits for laboratory or research use containing one or more of polymerase chain reaction (PCR) reagents, polymerase chain reaction (PCR) primers, cell culture medias, biochemical reagents used for non-medical purposes, reagents for use in scientific apparatus for chemical or biological analysis, reagents for in vitro use in biochemistry and clinical microbiology, and cell culture reagents for scientific and research use; Reagents and consumables for scientific or research use used in connection with polymerase chain reaction (PCR), molecular diagnostics, and gene analysis, namely, polymerase chain reaction (PCR) master mixes, quantitative polymerase chain reaction (qPCR) master mixes, polymerase chain reaction (PCR) reagents comprising polymerase enzymes, deoxynucleotides (dNTPs), aptamer and antibody hot start mechanisms, reverse-transcription enzymes, biochemical reagents used for non-medical purposes, reagents for use in scientific apparatus for biological analysis, and cell culture reagents all for scientific and research use

Reagents for medical diagnostic use used in gene analysis and sequencing as well as DNA and RNA analysis and sequencing, namely, polymerase chain reaction (PCR) master mixes, polymerase chain reaction (PCR) reagents and enzymes, polymerase chain reaction (PCR) test kits containing DNA primers and template control DNA for polymerase chain reaction (PCR), all for medical diagnostic use, diagnostic biomarker reagents for medical purposes, diagnostic reagents for medical use, medical diagnostic reagents for the analysis of body fluids, medical diagnostic reagents and assays for testing body fluids for microorganisms, and diagnostic reagents and assays for diagnostic testing of medical samples for microorganisms, pathogens, genotypes, and viruses; Reagents for medical diagnostic use used in the collection, storage and preparation of materials for gene analysis and sequencing as well as DNA and RNA analysis and sequencing, and in DNA extraction systems for crude lysates, DNA purification systems and cell filtration systems, diagnostic biomarker reagents for medical purposes, diagnostic reagents for medical use, medical diagnostic reagents for the analysis of body fluids, and medical diagnostic reagents and assays for testing body fluids for microorganisms; Reagents for medical diagnostic use used in detecting pathogens and genetic mutations, namely, test kits for medical diagnostic use containing one or more of polymerase chain reaction (PCR) reagents, polymerase chain reaction (PCR) primers, cell culture medias, and diagnostic reagents and assays for diagnostic testing of medical samples for microorganisms, pathogens, genotypes, and viruses; Reagents and consumables for medical diagnostic use used in connection with polymerase chain reaction (PCR), molecular diagnostics, and gene analysis, namely, polymerase chain reaction (PCR) master mixes, quantitative polymerase chain reaction (qPCR) master mixes, polymerase chain reaction (PCR) reagents comprising polymerase enzymes, deoxynucleotides (dNTPs), aptamer and antibody hot start mechanisms, and reverse-transcription enzymes, all for medical diagnostic use

DNA amplification apparatus, namely, thermocyclers for DNA and RNA testing for medical purposes

Filing History

CANCELLATION GRANTED NO. 999999
May 27, 2026 CANG
CANCELLATION INSTITUTED NO. 999999
Jan 15, 2026 PETC
WITHDRAWAL OF ATTORNEY GRANTED
Oct 16, 2025 WOAG
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Oct 16, 2025 WOAR
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jan 14, 2025 REM1
REGISTERED-PRINCIPAL REGISTER
Jan 14, 2020 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Dec 13, 2019 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Dec 12, 2019 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Nov 22, 2019 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 22, 2019 AITU
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Nov 20, 2019 ASGN
USE AMENDMENT FILED
Nov 13, 2019 IUAF
TEAS STATEMENT OF USE RECEIVED
Nov 13, 2019 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 14, 2019 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 19, 2019 NPUB
PUBLISHED FOR OPPOSITION
Mar 19, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 27, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 8, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 16, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 16, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 16, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 16, 2019 CNEA
EXAMINER'S AMENDMENT ENTERED
Jan 11, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 11, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 11, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 11, 2019 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 18, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 18, 2018 CRFA
ASSIGNED TO LIE
Dec 14, 2018 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 11, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 18, 2018 GNRN
NON-FINAL ACTION E-MAILED
Jun 18, 2018 GNRT
NON-FINAL ACTION WRITTEN
Jun 18, 2018 CNRT
ASSIGNED TO EXAMINER
Jun 12, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 7, 2018 NWOS
NEW APPLICATION ENTERED
Mar 3, 2018 NWAP